Action needed to preserve the six protected classes
By Tom Wilbur | February 3, 2021
In the final hours of the previous Administration’s time in office, the Center for Medicare & Medicaid Innovation (the Innovation Center) (CMMI) announced new changes for CY 2022 to an existing...
Read More
Study finds biopharmaceutical innovation is responsible for 35% of the increase in life expectancy from 1990 to 2015
By Gabby Migliara | October 21, 2020
Medicines are responsible for more than a third of the improvement in life expectancy from 1990 to 2015, according to a recent study published in Health Affairs. This underscores the crucial role...
Read More
Proposed change to Medicaid line extension definition ignores importance of critical improvements in treatments
By Nicole Longo | October 13, 2020
In comments recently submitted to the administration, PhRMA raised concerns with a number of changes included in the Centers for Medicare & Medicaid Services (CMS) Medicaid proposed rule. Today,...
Read More
Commercial health plans have increased patients’ out-of-pocket costs by over 50% in some therapeutic areas
By Gabby Migliara | August 12, 2020
According to a recent IQVIA analysis, commercial health plans have increased patients’ average out-of-pocket costs for brand medicines by over 50% in some therapeutic areas since 2015. Notably, of...
Read More
Changes to the six protected class policy are the wrong prescription for Medicare and HIV patients
By Tom Wilbur | March 15, 2019
For over 10 years, one of the cornerstones of the Medicare Part D program has been to ensure the sickest and most vulnerable patients have access to the clinically critical medicines they rely on....
Read More
World AIDS Day 2018: Hope for the future
By Andrew Powaleny | December 1, 2018
Each year, I write to commemorate World AIDS Day which is now in its 30th year spotlighting patients living with HIV and those we’ve sadly lost to AIDS-related illnesses.
Read More
Guest post: Excellent care for LGBTQ patients requires cultural humility and specific medical knowledge
By Guest Contributor | June 28, 2018
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...
Read More
Diversity of thought fuels next generation of breakthroughs
By Andrew Powaleny | June 7, 2018
This month, PhRMA is proud to join with our member companies to celebrate Lesbian, Gay, Bisexual and Transgender (LGBT) PRIDE Month.
Read More
World AIDS Day 2017: Scientific breakthroughs paving the way for an AIDS-free generation
By Andrew Powaleny | December 1, 2017
Today marks World AIDS Day, a moment to reflect on the significant advances made in the treatment and prevention of HIV, the virus which causes AIDS. The incredible scientific progress...
Read More
More than 50 medicines and vaccines in development for HIV infection, treatment and prevention
By Andrew Powaleny | June 27, 2017
From the introduction of anti-retroviral therapy (ART) in the mid-1990’s, to the discovery of medicines that prevent the transmission of HIV, America’s biopharmaceutical companies are leading the ...
Read More
Medicare Monday (100)
340B Spotlight (46)
Cost & Consequence (0)
